IP Library Assignment 031246/0485
Patent Assignment
Reel/Frame 031246/0485

Merger

Recorded: 2013-09-20 Pages: 7
Assignor
CURAGEN CORPORATION
Executed: 2009-12-31
Assignee
CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE, NEEDHAM, MASSACHUSETTS, 02494
Covered Property (1)
Antibodies Directed to Gpnmb and Uses Thereof
Patent: 8,846,873 →
Application: 13/355,366 →
Publication: US 2013/0022597
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2013
From: FENG, XIAO; JIA, XIAO-CHI; LIANG, MEINA; FOORD, ORIT
To: AMGEN FREMONT, INC.
Reel/Frame 031245/0859 →
Assignment of Assignor's Interest Sep 20, 2013
From: TSE, KAM FAI; POLLACK, VINCENT; RASTELLI, LUCA; LICHENSTEIN, HENRI
To: CURAGEN CORPORATION
Reel/Frame 031246/0007 →
Assignment of Assignor's Interest Sep 20, 2013
From: KARKARIA, CYRUS; TORGOV, MICHAEL; DAVAGNINO, JUAN
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 031246/0203 →
Assignment of Assignor's Interest Sep 20, 2013
From: HERRMANN, JOHN
To: CURAGEN CORPORATION
Reel/Frame 031246/0347 →